Skip navigation
Three Persistent Myths Muddying the Peptide Conversation
0:00

Three Persistent Myths Muddying the Peptide Conversation

#peptidescience #functionalmedicine #evidencebasedmedicine

Three Persistent Myths Muddying the Peptide Conversation Peptides have moved from the margins of sports medicine and longevity research into mainstream clinical conversations, and with that shift has come a wave of misinformation circulating across social platforms. @thezunigas addresses three of the most persistent misconceptions directly, each worth examining through a clinical lens. The first involves bacteriostatic water (BW), the sterile diluent used to reconstitute lyophilized peptides. The widely repeated "28-day rule" is often misapplied. Bacteriostatic water contains 0.9% benzyl alcohol, a preservative that inhibits microbial growth over an extended period. The 28-day figure originates from multi-dose vial guidelines in hospital pharmacy settings, not from the chemical stability of BW itself. Proper storage conditions, sterile technique, and the specific peptide being reconstituted all factor into actual shelf life considerations. The second myth targets GHK-Cu, a copper-binding tripeptide studied for its roles in wound healing, anti-inflammatory signaling, and tissue remodeling. The claim that it requires cycling, the way anabolic compounds sometimes do to prevent receptor downregulation or hormonal suppression, is not supported by its mechanism of action. GHK-Cu does not interact with the hypothalamic-pituitary axis in the same manner. The third and most consequential myth is that peptides cause cancer. This conflates distinct compound classes. Research on peptides such as GHK-Cu has actually investigated potential anti-tumor properties, not carcinogenicity. The concern typically arises from confusion with growth hormone secretagogues, a pharmacologically separate category with its own evidence profile. #PeptideScience #FunctionalMedicine #EvidenceBasedMedicine

Comments

Comments from the original post on Instagram

No comments yet